Shopping Cart
- Remove All
- Your shopping cart is currently empty
5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms.
Description | 5MPN is an orally active and selective inhibitor of 6-phosphofructokinase-2-kinase (PFKFB4) that competitively inhibits the F6P binding site and inhibits the proliferation of myeloma cells, and can be used in the study of myeloproliferative neoplasms. |
Targets&IC50 | PFKFB4:8.6 μM (Ki) |
In vitro | In H460 cells, 5MPN (0-30 μM; 24 hours) is able to inhibit the expression of PFKFB4[2]. |
In vivo | 5MPN (120 mg/kg; p.o.) effectively inhibits the growth of Lewis lung carcinomas (LLC) in C57BL/6 mice and H460 human lung adenocarcinoma xenografts in athymic mice, without impacting body weight. A decline in Ki67-positive cells within LLC xenografts suggests 5MPN interferes with cell cycle progression in vivo[1]. |
Alias | 5-MPN |
Molecular Weight | 305.33 |
Formula | C15H19N3O4 |
Cas No. | 47208-82-2 |
Smiles | COc1cccc2c(NCCCCCO[N+]([O-])=O)ccnc12 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (262.01 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.